Sponsor or institution
Clinical trials and research at Dongzhimen Hospital, Beijing
As of November 12, 2026, Find a Trial lists 7 clinical trials run by Dongzhimen Hospital, Beijing that are recruiting, in China. By phase: Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Sequential Traditional Chinese Medicine in Alzheimer's Disease: See How Symptoms Change Over Time | — | Beijing, Beijing Municipality | Recruiting | Aug 17, 2026 |
| Registry for people with cerebral small vessel disease. | — | Beijing, Beijing Municipality | Recruiting | Jan 15, 2026 |
| Qingre Huatan formula to prevent early neurological worsening after acute ischemic stroke | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Mar 4, 2025 |
| Using Yiqilishui formula to treat heart dysfunction caused by sepsis | Phase 2 | Beijing | Recruiting | Nov 13, 2024 |
| Exploring the link between PLA levels and severity of sepsis cardiac insufficiency | — | Beijing, Beijing Municipality | Recruiting | Oct 23, 2024 |
| Examining the link between ovarian function and serum biomarkers | — | Beijing | Recruiting | Oct 24, 2023 |
| Registry of ALS patients receiving Traditional Chinese Medicine | — | Beijing | Recruiting | May 13, 2021 |
All recruiting trials (7)
-
Sequential Traditional Chinese Medicine in Alzheimer's Disease: See How Symptoms Change Over Time
This observational study tests whether stage-based sequential traditional Chinese medicine can influence memory, daily function, and behavior in people with Alzheimer's disease or mild cognitive impairment.
-
Registry for people with cerebral small vessel disease.
This project will collect clinical information and MRI scans from people aged 50 and older with MRI signs of cerebral small vessel disease to see how the condition relates to thinking, walking, and daily function over time.
-
Qingre Huatan formula to prevent early neurological worsening after acute ischemic stroke
This study will test whether adding the Qingre Huatan herbal formula to standard care can prevent early neurological worsening in adults who have had an acute ischemic stroke within 48 hours of symptom onset.
-
Using Yiqilishui formula to treat heart dysfunction caused by sepsis
This study is testing if a traditional Chinese medicine called Yiqilishui can help improve heart function in people with heart problems caused by sepsis.
-
Exploring the link between PLA levels and severity of sepsis cardiac insufficiency
This study is looking to see if higher levels of PLA in the blood are linked to how severe heart problems are in older patients with sepsis.
-
Examining the link between ovarian function and serum biomarkers
This study is trying to see how blood markers differ between healthy women and those with ovarian issues to better understand their connection.
-
Registry of ALS patients receiving Traditional Chinese Medicine
This study is creating a registry to track ALS patients who are using traditional Chinese medicine to see how it affects their health over five years.
Quick answers
How many clinical trials run by Dongzhimen Hospital, Beijing are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.